Literature DB >> 7666526

In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates.

B D Jamieson1, S Pang, G M Aldrovandi, J Zha, J A Zack.   

Abstract

We have investigated the in vivo pathogenic properties of two molecularly cloned strains of human immunodeficiency virus type 1 (HIV-1), HIV-1NL4-3 and HIV-1JR-CSF, in human fetal thymus/liver implants in severe combined immunodeficient mice. Studies comparing their in vivo replication kinetics and abilities to induce CD4+ thymocyte depletion were performed. HIV-1NL4-3 replicated in vivo with faster kinetics and induced greater levels of CD4+ thymocyte depletion than did HIV-1JR-CSF. These results demonstrate that different viral isolates have different pathogenic properties in this system. In the SCID-hu model, this pathogenesis most likely occurs in the absence of an immune response. Therefore, we investigated whether the absence of immune selection resulted in extensive genetic variation and the generation of viral quasispecies. To this end, DNA corresponding to the fourth variable domain region of the viral envelope gp120 protein recovered from biopsy samples at 6 weeks postinfection was sequenced. Little genetic variation was noted in either HIV-1JR-CSF- or HIV-1NL4-3-infected implants. The mutation levels demonstrated in both viral strains were more reflective of the acute rather than the chronic phase of HIV-1 infection in humans. These results suggest that the SCID-hu mouse model can be used to study the in vivo pathogenicity of different HIV-1 isolates in the absence of host immune selective pressures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666526      PMCID: PMC189523     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Rapid generation of sequence variation during primary HIV-1 infection.

Authors:  S Pang; Y Shlesinger; E S Daar; T Moudgil; D D Ho; I S Chen
Journal:  AIDS       Date:  1992-05       Impact factor: 4.177

2.  Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.

Authors:  B D Jamieson; G M Aldrovandi; V Planelles; J B Jowett; L Gao; L M Bloch; I S Chen; J A Zack
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  HIV induces thymus depletion in vivo.

Authors:  M L Bonyhadi; L Rabin; S Salimi; D A Brown; J Kosek; J M McCune; H Kaneshima
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

4.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

5.  Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

Authors:  R I Connor; H Mohri; Y Cao; D D Ho
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates.

Authors:  D E Mosier; R J Gulizia; P D MacIsaac; B E Torbett; J A Levy
Journal:  Science       Date:  1993-04-30       Impact factor: 47.728

7.  Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle.

Authors:  J A Zack; A M Haislip; P Krogstad; I S Chen
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Sequential determination of viral load and phenotype in human immunodeficiency virus type 1 infection.

Authors:  E S Daar; T Chernyavskiy; J Q Zhao; P Krogstad; I S Chen; J A Zack
Journal:  AIDS Res Hum Retroviruses       Date:  1995-01       Impact factor: 2.205

9.  The SCID-hu mouse as a model for HIV-1 infection.

Authors:  G M Aldrovandi; G Feuer; L Gao; B Jamieson; M Kristeva; I S Chen; J A Zack
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

10.  Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.

Authors:  S K Stanley; J M McCune; H Kaneshima; J S Justement; M Sullivan; E Boone; M Baseler; J Adelsberger; M Bonyhadi; J Orenstein
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  23 in total

1.  R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.

Authors:  R D Berkowitz; A B van't Wout; N A Kootstra; M E Moreno; V D Linquist-Stepps; C Bare; C A Stoddart; H Schuitemaker; J M McCune
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.

Authors:  S G Kitchen; S Killian; J V Giorgi; J A Zack
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection.

Authors:  S G Kitchen; C H Uittenbogaart; J A Zack
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication.

Authors:  D Camerini; H P Su; G Gamez-Torre; M L Johnson; J A Zack; I S Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.

Authors:  R M Scoggins; J R Taylor; J Patrie; A B van't Wout; H Schuitemaker; D Camerini
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo.

Authors:  B D Jamieson; C H Uittenbogaart; I Schmid; J A Zack
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  HIV-1 pathogenesis and therapeutic intervention in the SCID-hu Thy/Liv mouse: a model for primary HIV-1 infection in the human thymus.

Authors: 
Journal:  Rev Med Virol       Date:  1997-09       Impact factor: 6.989

8.  Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo.

Authors:  P S Koka; J K Fraser; Y Bryson; G C Bristol; G M Aldrovandi; E S Daar; J A Zack
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 9.  Studies of retroviral infection in humanized mice.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Virology       Date:  2015-02-11       Impact factor: 3.616

10.  Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Authors:  G M Aldrovandi; J A Zack
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.